Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Clinical trial NCT05514548 · COMPLETED

Trial details

NCT number: NCT05514548
Sponsor: Inversago Pharma Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease

Start date: 2022-10-19
Primary completion: 2024-08-20
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.